ID   ARGI1_HUMAN             Reviewed;         322 AA.
AC   P05089; A6NEA0; Q5JWT5; Q5JWT6; Q8TE72; Q9BS50;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2001, sequence version 2.
DT   22-JUL-2015, entry version 188.
DE   RecName: Full=Arginase-1;
DE            EC=3.5.3.1;
DE   AltName: Full=Liver-type arginase;
DE   AltName: Full=Type I arginase;
GN   Name=ARG1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=3540966; DOI=10.1073/pnas.84.2.412;
RA   Haraguchi Y., Takiguchi M., Amaya Y., Kawamoto S., Matsuda I.,
RA   Mori M.;
RT   "Molecular cloning and nucleotide sequence of cDNA for human liver
RT   arginase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:412-415(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Blood;
RX   PubMed=3174433; DOI=10.1093/nar/16.18.8789;
RA   Takiguchi M., Haraguchi Y., Mori M.;
RT   "Human liver-type arginase gene: structure of the gene and analysis of
RT   the promoter region.";
RL   Nucleic Acids Res. 16:8789-8802(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Erythroblast;
RA   Lee Y.T., Miller J.L.;
RL   Submitted (JAN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Liver, and Skeletal muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-13, AND SUBUNIT.
RC   TISSUE=Liver;
RX   PubMed=2241902;
RA   Ikemoto M., Tabata M., Miyake T., Kono T., Mori M., Totani M.,
RA   Murachi T.;
RT   "Expression of human liver arginase in Escherichia coli. Purification
RT   and properties of the product.";
RL   Biochem. J. 270:697-703(1990).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-62; SER-163 AND SER-217,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.29 ANGSTROMS) IN COMPLEX WITH MANGANESE IONS
RP   AND THE SYNTHETIC INHIBITOR 2(S)-AMINO-6-BORONOHEXANOIC ACID,
RP   SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=16141327; DOI=10.1073/pnas.0504027102;
RA   Di Costanzo L., Sabio G., Mora A., Rodriguez P.C., Ochoa A.C.,
RA   Centeno F., Christianson D.W.;
RT   "Crystal structure of human arginase I at 1.29-A resolution and
RT   exploration of inhibition in the immune response.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:13058-13063(2005).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) IN COMPLEX WITH MANGANESE IONS
RP   AND THE SYNTHETIC INHIBITOR 2(S)-AMINO-6-BORONOHEXANOIC ACID, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=17562323; DOI=10.1016/j.abb.2007.04.036;
RA   Di Costanzo L., Moulin M., Haertlein M., Meilleur F.,
RA   Christianson D.W.;
RT   "Expression, purification, assay, and crystal structure of
RT   perdeuterated human arginase I.";
RL   Arch. Biochem. Biophys. 465:82-89(2007).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) IN COMPLEX WITH MANGANESE IONS
RP   AND THIOSEMICARBAZIDE, AND SUBUNIT.
RX   PubMed=17469833; DOI=10.1021/ja071567j;
RA   Di Costanzo L., Pique M.E., Christianson D.W.;
RT   "Crystal structure of human arginase I complexed with
RT   thiosemicarbazide reveals an unusual thiocarbonyl mu-sulfide ligand in
RT   the binuclear manganese cluster.";
RL   J. Am. Chem. Soc. 129:6388-6389(2007).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.51 ANGSTROMS) IN COMPLEX WITH MANGANESE IONS
RP   AND THE SYNTHETIC INHIBITOR (2S)-2-AMINO-7,8-EPOXYOCTANOIC ACID.
RX   PubMed=18802628; DOI=10.1039/b811797g;
RA   Zakharian T.Y., Di Costanzo L., Christianson D.W.;
RT   "Synthesis of (2S)-2-amino-7,8-epoxyoctanoic acid and structure of its
RT   metal-bridging complex with human arginase I.";
RL   Org. Biomol. Chem. 6:3240-3243(2008).
RN   [14]
RP   VARIANT ARGIN ARG-235.
RX   PubMed=1463019;
RA   Uchino T., Haraguchi Y., Aparicio J.M., Mizutani N., Higashikawa M.,
RA   Naitoh H., Mori M., Matsuda I.;
RT   "Three novel mutations in the liver-type arginase gene in three
RT   unrelated Japanese patients with argininemia.";
RL   Am. J. Hum. Genet. 51:1406-1412(1992).
RN   [15]
RP   VARIANT SER-290.
RX   PubMed=1598908;
RA   Grody W.W., Klein D., Dodson A.E., Kern R.M., Wissmann P.B.,
RA   Goodman B.K., Bassand P., Marescau B., Kang S.-S., Leonard J.V.,
RA   Cederbaum S.D.;
RT   "Molecular genetic study of human arginase deficiency.";
RL   Am. J. Hum. Genet. 50:1281-1290(1992).
RN   [16]
RP   VARIANTS ARGIN THR-11 AND VAL-138.
RX   PubMed=7649538; DOI=10.1007/BF00210403;
RA   Uchino T., Snyderman S.E., Lambert M., Qureshi I.A., Shapira S.K.,
RA   Sansaricq C., Smit L.M.E., Jakobs C., Matsuda I.;
RT   "Molecular basis of phenotypic variation in patients with
RT   argininemia.";
RL   Hum. Genet. 96:255-260(1995).
RN   [17]
RP   VARIANTS ARGIN THR-11; ASP-27; VAL-74; ILE-134 AND GLN-308.
RX   PubMed=22959135; DOI=10.1016/j.gene.2012.08.003;
RA   Carvalho D.R., Brand G.D., Brum J.M., Takata R.I., Speck-Martins C.E.,
RA   Pratesi R.;
RT   "Analysis of novel ARG1 mutations causing hyperargininemia and
RT   correlation with arginase I activity in erythrocytes.";
RL   Gene 509:124-130(2012).
RN   [18]
RP   VARIANTS ARGIN VAL-125; THR-180 AND ARG-235.
RX   PubMed=23859858; DOI=10.1016/j.pediatrneurol.2013.04.026;
RA   Wu T.F., Liu Y.P., Li X.Y., Wang Q., Ding Y., Ma Y.Y., Song J.Q.,
RA   Yang Y.L.;
RT   "Five novel mutations in ARG1 gene in Chinese patients of
RT   argininemia.";
RL   Pediatr. Neurol. 49:119-123(2013).
CC   -!- CATALYTIC ACTIVITY: L-arginine + H(2)O = L-ornithine + urea.
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC       Note=Binds 2 manganese ions per subunit.;
CC   -!- PATHWAY: Nitrogen metabolism; urea cycle; L-ornithine and urea
CC       from L-arginine: step 1/1.
CC   -!- SUBUNIT: Homotrimer. {ECO:0000269|PubMed:16141327,
CC       ECO:0000269|PubMed:17469833, ECO:0000269|PubMed:17562323,
CC       ECO:0000269|PubMed:18802628, ECO:0000269|PubMed:2241902}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16141327}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P05089-1; Sequence=Displayed;
CC       Name=2; Synonyms=Erythroid variant;
CC         IsoId=P05089-2; Sequence=VSP_009330;
CC         Note=May be due to a competing acceptor splice site. No
CC         experimental confirmation available.;
CC       Name=3;
CC         IsoId=P05089-3; Sequence=VSP_009331;
CC   -!- INDUCTION: By arginine or homoarginine.
CC   -!- DISEASE: Argininemia (ARGIN) [MIM:207800]: A rare autosomal
CC       recessive disorder of the urea cycle. Arginine is elevated in the
CC       blood and cerebrospinal fluid, and periodic hyperammonemia occurs.
CC       Clinical manifestations include developmental delay, seizures,
CC       mental retardation, hypotonia, ataxia and progressive spastic
CC       quadriplegia. {ECO:0000269|PubMed:1463019,
CC       ECO:0000269|PubMed:22959135, ECO:0000269|PubMed:23859858,
CC       ECO:0000269|PubMed:7649538}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the arginase family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00742}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Arginase entry;
CC       URL="http://en.wikipedia.org/wiki/Arginase";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M14502; AAA51776.1; -; mRNA.
DR   EMBL; X12662; CAA31188.1; -; Genomic_DNA.
DR   EMBL; X12663; CAA31188.1; JOINED; Genomic_DNA.
DR   EMBL; X12664; CAA31188.1; JOINED; Genomic_DNA.
DR   EMBL; X12665; CAA31188.1; JOINED; Genomic_DNA.
DR   EMBL; X12666; CAA31188.1; JOINED; Genomic_DNA.
DR   EMBL; X12667; CAA31188.1; JOINED; Genomic_DNA.
DR   EMBL; X12668; CAA31188.1; JOINED; Genomic_DNA.
DR   EMBL; X12669; CAA31188.1; JOINED; Genomic_DNA.
DR   EMBL; AY074488; AAL71547.1; -; mRNA.
DR   EMBL; BT006741; AAP35387.1; -; mRNA.
DR   EMBL; AL121575; CAB92071.1; -; Genomic_DNA.
DR   EMBL; AL121575; CAI23317.1; -; Genomic_DNA.
DR   EMBL; AL121575; CAI23318.1; -; Genomic_DNA.
DR   EMBL; BC005321; AAH05321.1; -; mRNA.
DR   EMBL; BC020653; AAH20653.1; -; mRNA.
DR   CCDS; CCDS5145.1; -. [P05089-1]
DR   CCDS; CCDS59038.1; -. [P05089-2]
DR   PIR; S02132; A26370.
DR   RefSeq; NP_000036.2; NM_000045.3. [P05089-1]
DR   RefSeq; NP_001231367.1; NM_001244438.1. [P05089-2]
DR   UniGene; Hs.440934; -.
DR   PDB; 1WVA; X-ray; 1.94 A; A/B=1-322.
DR   PDB; 1WVB; X-ray; 2.30 A; A/B=1-322.
DR   PDB; 2AEB; X-ray; 1.29 A; A/B=1-322.
DR   PDB; 2PHA; X-ray; 1.90 A; A/B=1-322.
DR   PDB; 2PHO; X-ray; 1.95 A; A/B=1-322.
DR   PDB; 2PLL; X-ray; 1.90 A; A/B=1-322.
DR   PDB; 2ZAV; X-ray; 1.70 A; A/B=1-322.
DR   PDB; 3DJ8; X-ray; 1.51 A; A/B=1-322.
DR   PDB; 3E6K; X-ray; 2.10 A; A/B=1-322.
DR   PDB; 3E6V; X-ray; 1.72 A; A/B=1-322.
DR   PDB; 3F80; X-ray; 1.60 A; A/B=1-322.
DR   PDB; 3GMZ; X-ray; 1.43 A; A/B=1-322.
DR   PDB; 3GN0; X-ray; 1.70 A; A/B=1-322.
DR   PDB; 3KV2; X-ray; 1.55 A; A/B=1-322.
DR   PDB; 3LP4; X-ray; 1.90 A; A/B=1-322.
DR   PDB; 3LP7; X-ray; 2.04 A; A/B=1-322.
DR   PDB; 3MFV; X-ray; 1.90 A; A/B=1-322.
DR   PDB; 3MFW; X-ray; 1.47 A; A/B=1-322.
DR   PDB; 3MJL; X-ray; 1.90 A; A/B=1-322.
DR   PDB; 3SJT; X-ray; 1.60 A; A/B=1-322.
DR   PDB; 3SKK; X-ray; 1.70 A; A/B=1-322.
DR   PDB; 3TF3; X-ray; 1.64 A; A/B=1-322.
DR   PDB; 3TH7; X-ray; 2.10 A; A/B=1-322.
DR   PDB; 3THE; X-ray; 1.97 A; A/B=1-322.
DR   PDB; 3THH; X-ray; 1.85 A; A/B=1-322.
DR   PDB; 3THJ; X-ray; 1.50 A; A/B=1-322.
DR   PDB; 4FCI; X-ray; 1.82 A; A/B=1-322.
DR   PDB; 4FCK; X-ray; 1.90 A; A/B=1-322.
DR   PDB; 4GSM; X-ray; 1.70 A; A/B=1-322.
DR   PDB; 4GSV; X-ray; 1.48 A; A/B=1-322.
DR   PDB; 4GSZ; X-ray; 2.20 A; A/B=1-322.
DR   PDB; 4GWC; X-ray; 1.90 A; A/B=1-322.
DR   PDB; 4GWD; X-ray; 1.53 A; A/B=1-322.
DR   PDB; 4HWW; X-ray; 1.30 A; A/B=5-318.
DR   PDB; 4HXQ; X-ray; 1.45 A; A/B=5-318.
DR   PDB; 4IE1; X-ray; 2.00 A; A/B=5-318.
DR   PDBsum; 1WVA; -.
DR   PDBsum; 1WVB; -.
DR   PDBsum; 2AEB; -.
DR   PDBsum; 2PHA; -.
DR   PDBsum; 2PHO; -.
DR   PDBsum; 2PLL; -.
DR   PDBsum; 2ZAV; -.
DR   PDBsum; 3DJ8; -.
DR   PDBsum; 3E6K; -.
DR   PDBsum; 3E6V; -.
DR   PDBsum; 3F80; -.
DR   PDBsum; 3GMZ; -.
DR   PDBsum; 3GN0; -.
DR   PDBsum; 3KV2; -.
DR   PDBsum; 3LP4; -.
DR   PDBsum; 3LP7; -.
DR   PDBsum; 3MFV; -.
DR   PDBsum; 3MFW; -.
DR   PDBsum; 3MJL; -.
DR   PDBsum; 3SJT; -.
DR   PDBsum; 3SKK; -.
DR   PDBsum; 3TF3; -.
DR   PDBsum; 3TH7; -.
DR   PDBsum; 3THE; -.
DR   PDBsum; 3THH; -.
DR   PDBsum; 3THJ; -.
DR   PDBsum; 4FCI; -.
DR   PDBsum; 4FCK; -.
DR   PDBsum; 4GSM; -.
DR   PDBsum; 4GSV; -.
DR   PDBsum; 4GSZ; -.
DR   PDBsum; 4GWC; -.
DR   PDBsum; 4GWD; -.
DR   PDBsum; 4HWW; -.
DR   PDBsum; 4HXQ; -.
DR   PDBsum; 4IE1; -.
DR   ProteinModelPortal; P05089; -.
DR   SMR; P05089; 5-318.
DR   BioGrid; 106878; 14.
DR   IntAct; P05089; 8.
DR   MINT; MINT-3974693; -.
DR   STRING; 9606.ENSP00000357066; -.
DR   BindingDB; P05089; -.
DR   ChEMBL; CHEMBL1075097; -.
DR   DrugBank; DB00129; L-Ornithine.
DR   PhosphoSite; P05089; -.
DR   BioMuta; ARG1; -.
DR   DMDM; 12230985; -.
DR   MaxQB; P05089; -.
DR   PaxDb; P05089; -.
DR   PRIDE; P05089; -.
DR   DNASU; 383; -.
DR   Ensembl; ENST00000356962; ENSP00000349446; ENSG00000118520. [P05089-2]
DR   Ensembl; ENST00000368087; ENSP00000357066; ENSG00000118520.
DR   GeneID; 383; -.
DR   KEGG; hsa:383; -.
DR   UCSC; uc003qco.2; human. [P05089-1]
DR   UCSC; uc010kfm.2; human. [P05089-2]
DR   CTD; 383; -.
DR   GeneCards; GC06P131936; -.
DR   GeneReviews; ARG1; -.
DR   HGNC; HGNC:663; ARG1.
DR   HPA; CAB009434; -.
DR   HPA; CAB056159; -.
DR   HPA; HPA003595; -.
DR   HPA; HPA024006; -.
DR   MIM; 207800; phenotype.
DR   MIM; 608313; gene.
DR   neXtProt; NX_P05089; -.
DR   Orphanet; 90; Argininemia.
DR   PharmGKB; PA24947; -.
DR   eggNOG; COG0010; -.
DR   GeneTree; ENSGT00530000063082; -.
DR   HOGENOM; HOG000204319; -.
DR   HOVERGEN; HBG003030; -.
DR   InParanoid; P05089; -.
DR   KO; K01476; -.
DR   OMA; EQECDVK; -.
DR   OrthoDB; EOG747PJ5; -.
DR   PhylomeDB; P05089; -.
DR   TreeFam; TF300034; -.
DR   BioCyc; MetaCyc:HS04231-MONOMER; -.
DR   BRENDA; 3.5.3.1; 2681.
DR   Reactome; REACT_847; Urea cycle.
DR   SABIO-RK; P05089; -.
DR   UniPathway; UPA00158; UER00270.
DR   EvolutionaryTrace; P05089; -.
DR   GenomeRNAi; 383; -.
DR   NextBio; 1603; -.
DR   PRO; PR:P05089; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; P05089; -.
DR   CleanEx; HS_ARG1; -.
DR   Genevisible; P05089; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IEA:Ensembl.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IEA:Ensembl.
DR   GO; GO:0043005; C:neuron projection; IEA:Ensembl.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0004053; F:arginase activity; EXP:Reactome.
DR   GO; GO:0030145; F:manganese ion binding; IEA:Ensembl.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0006527; P:arginine catabolic process; TAS:ProtInc.
DR   GO; GO:0019547; P:arginine catabolic process to ornithine; IEA:Ensembl.
DR   GO; GO:0034641; P:cellular nitrogen compound metabolic process; TAS:Reactome.
DR   GO; GO:0071549; P:cellular response to dexamethasone stimulus; IEA:Ensembl.
DR   GO; GO:0071377; P:cellular response to glucagon stimulus; IEA:Ensembl.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IEA:Ensembl.
DR   GO; GO:0071353; P:cellular response to interleukin-4; IEA:Ensembl.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl.
DR   GO; GO:0071560; P:cellular response to transforming growth factor beta stimulus; IEA:Ensembl.
DR   GO; GO:0032964; P:collagen biosynthetic process; IEA:Ensembl.
DR   GO; GO:0001889; P:liver development; IEA:Ensembl.
DR   GO; GO:0030324; P:lung development; IEA:Ensembl.
DR   GO; GO:0060056; P:mammary gland involution; IEA:Ensembl.
DR   GO; GO:0060135; P:maternal process involved in female pregnancy; IEA:Ensembl.
DR   GO; GO:0001938; P:positive regulation of endothelial cell proliferation; IEA:Ensembl.
DR   GO; GO:0070207; P:protein homotrimerization; IEA:Ensembl.
DR   GO; GO:0010963; P:regulation of L-arginine import; IEA:Ensembl.
DR   GO; GO:0014075; P:response to amine; IEA:Ensembl.
DR   GO; GO:0043200; P:response to amino acid; IEA:Ensembl.
DR   GO; GO:0048678; P:response to axon injury; IEA:Ensembl.
DR   GO; GO:0046686; P:response to cadmium ion; IEA:Ensembl.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0009635; P:response to herbicide; IEA:Ensembl.
DR   GO; GO:0010042; P:response to manganese ion; IEA:Ensembl.
DR   GO; GO:0051597; P:response to methylmercury; IEA:Ensembl.
DR   GO; GO:0010269; P:response to selenium ion; IEA:Ensembl.
DR   GO; GO:0033189; P:response to vitamin A; IEA:Ensembl.
DR   GO; GO:0033197; P:response to vitamin E; IEA:Ensembl.
DR   GO; GO:0010043; P:response to zinc ion; IEA:Ensembl.
DR   GO; GO:0044281; P:small molecule metabolic process; TAS:Reactome.
DR   GO; GO:0000050; P:urea cycle; TAS:Reactome.
DR   Gene3D; 3.40.800.10; -; 1.
DR   InterPro; IPR014033; Arginase.
DR   InterPro; IPR006035; Ureohydrolase.
DR   InterPro; IPR023696; Ureohydrolase_domain.
DR   InterPro; IPR020855; Ureohydrolase_Mn_BS.
DR   PANTHER; PTHR11358; PTHR11358; 1.
DR   Pfam; PF00491; Arginase; 1.
DR   PIRSF; PIRSF036979; Arginase; 1.
DR   PRINTS; PR00116; ARGINASE.
DR   TIGRFAMs; TIGR01229; rocF_arginase; 1.
DR   PROSITE; PS01053; ARGINASE_1; 1.
DR   PROSITE; PS51409; ARGINASE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Arginine metabolism;
KW   Complete proteome; Cytoplasm; Disease mutation; Hydrolase; Manganese;
KW   Metal-binding; Phosphoprotein; Polymorphism; Reference proteome;
KW   Urea cycle.
FT   CHAIN         1    322       Arginase-1.
FT                                /FTId=PRO_0000173693.
FT   REGION      126    130       Substrate binding.
FT   REGION      137    139       Substrate binding.
FT   METAL       101    101       Manganese 1.
FT   METAL       124    124       Manganese 1.
FT   METAL       124    124       Manganese 2.
FT   METAL       126    126       Manganese 2.
FT   METAL       128    128       Manganese 1.
FT   METAL       232    232       Manganese 1.
FT   METAL       232    232       Manganese 2.
FT   METAL       234    234       Manganese 2.
FT   BINDING     183    183       Substrate.
FT   MOD_RES      17     17       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q61176}.
FT   MOD_RES      62     62       Phosphoserine.
FT                                {ECO:0000269|PubMed:24275569}.
FT   MOD_RES      72     72       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q61176}.
FT   MOD_RES      75     75       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q61176}.
FT   MOD_RES     163    163       Phosphoserine.
FT                                {ECO:0000269|PubMed:24275569}.
FT   MOD_RES     217    217       Phosphoserine.
FT                                {ECO:0000269|PubMed:24275569}.
FT   VAR_SEQ      43     43       Q -> QVTQNFLIL (in isoform 2).
FT                                {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_009330.
FT   VAR_SEQ     204    289       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.4}.
FT                                /FTId=VSP_009331.
FT   VARIANT      11     11       I -> T (in ARGIN; 12% of wild-type
FT                                activity; dbSNP:rs28941474).
FT                                {ECO:0000269|PubMed:22959135,
FT                                ECO:0000269|PubMed:7649538}.
FT                                /FTId=VAR_015594.
FT   VARIANT      27     27       G -> D (in ARGIN; 5.2% of wild-type
FT                                activity). {ECO:0000269|PubMed:22959135}.
FT                                /FTId=VAR_072164.
FT   VARIANT      74     74       G -> V (in ARGIN; 9.3% of wild-type
FT                                activity). {ECO:0000269|PubMed:22959135}.
FT                                /FTId=VAR_072165.
FT   VARIANT     125    125       A -> V (in ARGIN; decreases erythrocyte
FT                                arginase activity).
FT                                {ECO:0000269|PubMed:23859858}.
FT                                /FTId=VAR_072166.
FT   VARIANT     134    134       T -> I (in ARGIN; 9.3% of wild-type
FT                                activity). {ECO:0000269|PubMed:22959135}.
FT                                /FTId=VAR_072167.
FT   VARIANT     138    138       G -> V (in ARGIN).
FT                                {ECO:0000269|PubMed:7649538}.
FT                                /FTId=VAR_015595.
FT   VARIANT     180    180       R -> T (in ARGIN; decreases erythrocyte
FT                                arginase activity).
FT                                {ECO:0000269|PubMed:23859858}.
FT                                /FTId=VAR_072168.
FT   VARIANT     235    235       G -> R (in ARGIN; decreases erythrocyte
FT                                arginase activity).
FT                                {ECO:0000269|PubMed:1463019,
FT                                ECO:0000269|PubMed:23859858}.
FT                                /FTId=VAR_000674.
FT   VARIANT     290    290       T -> S. {ECO:0000269|PubMed:1598908}.
FT                                /FTId=VAR_000675.
FT   VARIANT     308    308       R -> Q (in ARGIN; 20.8% of wild-type
FT                                activity). {ECO:0000269|PubMed:22959135}.
FT                                /FTId=VAR_072169.
FT   CONFLICT     48     48       K -> E (in Ref. 3; AAL71547).
FT                                {ECO:0000305}.
FT   CONFLICT     86     86       E -> Q (in Ref. 1; AAA51776).
FT                                {ECO:0000305}.
FT   CONFLICT    202    202       E -> K (in Ref. 3; AAL71547).
FT                                {ECO:0000305}.
FT   STRAND        7     13       {ECO:0000244|PDB:2AEB}.
FT   HELIX        22     26       {ECO:0000244|PDB:2AEB}.
FT   HELIX        27     33       {ECO:0000244|PDB:2AEB}.
FT   HELIX        36     42       {ECO:0000244|PDB:2AEB}.
FT   STRAND       46     52       {ECO:0000244|PDB:2AEB}.
FT   STRAND       67     69       {ECO:0000244|PDB:3TH7}.
FT   HELIX        70     89       {ECO:0000244|PDB:2AEB}.
FT   STRAND       93     99       {ECO:0000244|PDB:2AEB}.
FT   HELIX       101    103       {ECO:0000244|PDB:2AEB}.
FT   HELIX       104    114       {ECO:0000244|PDB:2AEB}.
FT   STRAND      119    126       {ECO:0000244|PDB:2AEB}.
FT   TURN        132    134       {ECO:0000244|PDB:2AEB}.
FT   HELIX       140    142       {ECO:0000244|PDB:2AEB}.
FT   HELIX       144    148       {ECO:0000244|PDB:2AEB}.
FT   HELIX       150    152       {ECO:0000244|PDB:2AEB}.
FT   TURN        153    155       {ECO:0000244|PDB:2AEB}.
FT   HELIX       171    173       {ECO:0000244|PDB:2AEB}.
FT   STRAND      174    179       {ECO:0000244|PDB:2AEB}.
FT   HELIX       184    193       {ECO:0000244|PDB:2AEB}.
FT   STRAND      196    199       {ECO:0000244|PDB:2AEB}.
FT   HELIX       200    206       {ECO:0000244|PDB:2AEB}.
FT   HELIX       208    220       {ECO:0000244|PDB:2AEB}.
FT   STRAND      221    223       {ECO:0000244|PDB:2AEB}.
FT   STRAND      227    232       {ECO:0000244|PDB:2AEB}.
FT   HELIX       233    235       {ECO:0000244|PDB:2AEB}.
FT   TURN        238    240       {ECO:0000244|PDB:2AEB}.
FT   STRAND      243    246       {ECO:0000244|PDB:2AEB}.
FT   HELIX       254    267       {ECO:0000244|PDB:2AEB}.
FT   STRAND      270    276       {ECO:0000244|PDB:2AEB}.
FT   HELIX       280    282       {ECO:0000244|PDB:2AEB}.
FT   HELIX       286    303       {ECO:0000244|PDB:2AEB}.
SQ   SEQUENCE   322 AA;  34735 MW;  8F3BE2652243F622 CRC64;
     MSAKSRTIGI IGAPFSKGQP RGGVEEGPTV LRKAGLLEKL KEQECDVKDY GDLPFADIPN
     DSPFQIVKNP RSVGKASEQL AGKVAEVKKN GRISLVLGGD HSLAIGSISG HARVHPDLGV
     IWVDAHTDIN TPLTTTSGNL HGQPVSFLLK ELKGKIPDVP GFSWVTPCIS AKDIVYIGLR
     DVDPGEHYIL KTLGIKYFSM TEVDRLGIGK VMEETLSYLL GRKKRPIHLS FDVDGLDPSF
     TPATGTPVVG GLTYREGLYI TEEIYKTGLL SGLDIMEVNP SLGKTPEEVT RTVNTAVAIT
     LACFGLAREG NHKPIDYLNP PK
//
